Everhart Financial Group »

Cognition Therapeutics shares owned by Everhart Financial Group

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Everhart Financial Group from 13F filings

Historical chart of Everhart Financial Group investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Everhart Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Everhart Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $43k 32k 1.35

More positions owned by Everhart Financial Group

Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Intermed Term (BIV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Meta Platforms Cl A (META)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Amazon (AMZN)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Broadcom (AVGO)

View all positions for Everhart Financial Group

Top funds holding Cognition Therapeutics

BIOS Capital Management
Davenport & Co
Vanguard Group
Tang Capital Management
Chescapmanager
BlackRock
Jane Street
Renaissance Technologies
Geode Capital Management
Hilton Capital Management
Millennium Management
State Street Corporation
Voss Capital
Graham Capital Management
American Financial Group

View all funds holding Cognition Therapeutics